Delivery Order SPE2DB22D9101-SPE2DB24FU7KS
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,580.64, is for the supply of 4565945539 - Fexofenadine HCL 180 mg Tablets in 500-count packages. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, with a potential value of up...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,154.60, is for the delivery of fexofenadine hydrochloride 180 mg tablets. The contract is not associated with any set-aside designation. It is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,154.60, is a firm fixed-price delivery order for the supply of 4567387654 ! FEXOFENADINE HCL 180 MG TABLET 500S, a prescription medication. The contract has an ultimate completion date of February 24, 2025. DMS Pharmaceutical Group Inc. also holds a larger Indefinite...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order valued at $2,460.12 issued by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,567,324,784 tablets of the pharmaceutical drug Fexofenadine HCL 180 mg and has a completion date of January 31, 2025. The contract is not associated with any set-aside designation. It is part of a larger $499,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,057.95 to DMS Pharmaceutical Group Inc. for the supply of Fexofenadine HCL 180 mg tablets (500-count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was issued without set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is headquartered. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $1,436.40 and an ultimate completion date of February 10, 2025. The contract is for the supply of 4,567,248,727 units of Fexofenadine HCL 180 mg tablets, a pharmaceutical product. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order valued at $1,903.78 for the provision of Fexofenadine HCL 180 mg tablets. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 500 tablets of fexofenadine hydrochloride 180 mg to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 500 tablets of Fexofenadine HCL 180 mg, with a ceiling value of $1,269.54. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, carries a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,395.39 firm fixed-price delivery order is for the supply of Fexofenadine 180mg tablets, a prescription antihistamine medication. The contract has an ultimate completion date of July 24, 2025 and was awarded on June 26, 2025. DMS Pharmaceutical Group holds a single-award Indefinite...
- SPE2DB22D9101Indefinite Delivery Contract
- SPE2DB22D9101-SPE2DB24FU7KSDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The contract is for the delivery of Fexofenadine Hydrochloride 180 mg tablets, with a potential value of $1,475.37 and a completion date of February 12, 2024. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDV) with the DLA, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. This IDV allows the DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities supported by the DLA worldwide. The current delivery order is part of this larger contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 2/9/24 |